SynthesisAging clinical and experimental research2026
Animal-assisted interventions for depression in older adults: an umbrella review with meta-analysis and trial sequential analysis.
Synthesis in Aging clinical and experimental research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDepression affects up to 30% of older adults and is associated with increased morbidity and mortality. Animal-assisted interventions (AAIs) - usually known as "pet therapy" - have emerged as promising complementary approaches, yet evidence synthesis remains fragmented.
objectiveTo comprehensively evaluate the effectiveness of AAI in reducing depressive symptoms among older adults through an umbrella review of systematic reviews and meta-analyses, incorporating trial sequential analysis.
methodsWe systematically searched PubMed, Embase, and Cochrane Library through September 2025 for systematic reviews and meta-analyses examining AAIs for depression in older adults. Quality assessment was performed using AMSTAR-2. We calculated the Corrected Covered Area to assess overlap between meta-analyses, re-analyzed primary study data to avoid double-counting, and conducted trial sequential analysis to evaluate evidence sufficiency.
resultsFive systematic reviews encompassing 27 unique primary studies with 2,156 participants were included. The pooled random-effects meta-analysis demonstrated a significant reduction in depressive symptoms (SMD = 0.73; 95% CI: 0.57-0.89; p < 0.001) with moderate heterogeneity (I² = 43.4%). Trial sequential analysis revealed that the cumulative Z-curve crossed monitoring boundaries at 75% of the required information size, confirming evidence sufficiency. The Corrected Covered Area was 20.4%, indicating moderate overlap between meta-analyses.
conclusionsAAIs are associated with clinically meaningful reductions in depressive symptoms among older adults. Trial sequential analysis confirms that sufficient evidence exists to support this conclusion. AAIs represent a valuable, low-risk, patient-centered complement to conventional depression treatments in geriatric care. PROSPERO REGISTRATION: [CRD420251250448].
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.